FAST NEWS: Kintor Pharma Raises $65 Million for Drug Commercialization
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Sunday that it will place 42 million shares, representing approximately 10.3% of its enlarged capital after the issue. It will sell the…
RELATED ARTICLES
-
Kintor Pharma eyes regeneration with over-the-counter cosmetic treatments
9939.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
1672.HK
-
Ascentage Pharma soars on deal with cancer drug competitor
6855.HK
-
BeiGene still bleeding red ink despite blockbuster drug
BGNE.US 6160.HK 688235.SHG
Discover hidden China stock gems in our weekly newsletter